Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature439: 353–357. ArticleCASPubMed Google Scholar
Cappellen D, Schlange T, Bauer M, Maurer F, Hynes NE . (2007). Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep8: 70–76. ArticleCASPubMed Google Scholar
Chang CC, Liu YC, Cleveland RP, Perkins SL . (2000). Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. Am J Clin Pathol113: 512–518. ArticleCASPubMed Google Scholar
Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet40: 43–50. ArticleCASPubMed Google Scholar
Chen Y, Stallings RL . (2007). Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res67: 976–983. ArticleCASPubMed Google Scholar
Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet38: 1060–1065. ArticleCASPubMedPubMed Central Google Scholar
Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. (2008). Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One3: e2236. ArticlePubMedPubMed Central Google Scholar
Fredlund E, Ringner M, Maris JM, Pahlman S . (2008). High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci USA105: 14094–14099. ArticleCASPubMedPubMed Central Google Scholar
Gartel AL . (2006). A new mode of transcriptional repression by c-myc: methylation. Oncogene25: 1989–1990. ArticleCASPubMed Google Scholar
Jiang M, Zhu K, Grenet J, Lahti JM . (2008). Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells. Biochim Biophys Acta1783: 1055–1067. ArticleCASPubMedPubMed Central Google Scholar
Kleine-Kohlbrecher D, Adhikary S, Eilers M . (2006). Mechanisms of transcriptional repression by Myc. Curr Top Microbiol Immunol302: 51–62. CASPubMed Google Scholar
Kramer MH, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken JH et al. (1998). Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood92: 3152–3162. CASPubMed Google Scholar
Landais S, Landry S, Legault P, Rassart E . (2007). Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res67: 5699–5707. ArticleCASPubMed Google Scholar
Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY . (2008). miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci11: 1137–1139. ArticleCASPubMedPubMed Central Google Scholar
Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H et al. (2008). Stromal gene signatures in large-B-cell lymphomas. N Engl J Med359: 2313–2323. ArticleCASPubMed Google Scholar
Liu Y, Ringner M . (2007). Revealing signaling pathway deregulation by using gene expression signatures and regulatory motif analysis. Genome Biol8: R77. ArticlePubMedPubMed Central Google Scholar
Malynn BA, de Alboran IM, O'Hagan RC, Bronson R, Davidson L, DePinho RA et al. (2000). N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev14: 1390–1399. CASPubMedPubMed Central Google Scholar
Mestdagh P, Feys T, Bernard N, Guenther S, Chen C, Speleman F et al. (2008). High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res36: e143. ArticlePubMedPubMed Central Google Scholar
Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F et al. (2009). A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol10: R64. ArticlePubMedPubMed Central Google Scholar
Northcott PA, Fernandez LA, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y et al. (2009). The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res69: 3249–3255. ArticleCASPubMedPubMed Central Google Scholar
O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature435: 839–843. ArticleCASPubMed Google Scholar
Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R et al. (2006). Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol24: 5070–5078. ArticleCASPubMed Google Scholar
Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A et al. (2001). Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry40: 3354–3362. ArticleCASPubMed Google Scholar
Peterson S, Bogenmann E . (2004). The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation. Oncogene23: 213–225. ArticleCASPubMed Google Scholar
Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T et al. (2003). PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res63: 1876–1883. CASPubMed Google Scholar
Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P et al. (2007). MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res67: 9762–9770. ArticleCASPubMed Google Scholar
Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF et al. (2008). MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood112: 4202–4212. ArticleCASPubMed Google Scholar
Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC et al. (2008). MYCN regulates oncogenic microRNAs in neuroblastoma. Int J Cancer122: 699–704. ArticleCASPubMed Google Scholar
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY et al. (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med313: 1111–1116. ArticleCASPubMed Google Scholar
Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N . (2008). Widespread changes in protein synthesis induced by microRNAs. Nature455: 58–63. ArticleCASPubMed Google Scholar
Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ et al. (2006). Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature439: 95–99. ArticleCASPubMed Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA102: 15545–15550. ArticleCASPubMedPubMed Central Google Scholar
Sun Y, Wu J, Wu SH, Thakur A, Bollig A, Huang Y et al. (2008). Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat118: 185–196. ArticlePubMed Google Scholar
Tan LP, Seinen E, Duns G, de Jong D, Sibon OC, Poppema S et al. (2009). A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Res37: e137. ArticlePubMedPubMed Central Google Scholar
Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R et al. (1994). 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer10: 103–114. ArticleCASPubMed Google Scholar
Van Roy N, Vandesompele J, Menten B, Nilsson H, De Smet E, Rocchi M et al. (2006). Translocation-excision-deletion-amplification mechanism leading to nonsyntenic coamplification of MYC and ATBF1. Genes Chromosomes Cancer45: 107–117. ArticleCASPubMed Google Scholar
Vandesompele J, Edsjo A, De Preter K, Axelson H, Speleman F, Pahlman S . (2003). ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene22: 456–460. ArticleCASPubMed Google Scholar
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA103: 2257–2261. ArticleCASPubMedPubMed Central Google Scholar
Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D et al. (2006). Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res66: 6050–6062. ArticleCASPubMed Google Scholar
Watters JW, Roberts CJ . (2006). Developing gene expression signatures of pathway deregulation in tumors. Mol Cancer Ther5: 2444–2449. ArticleCASPubMed Google Scholar
Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A et al. (2008). Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol9: R150. ArticlePubMedPubMed Central Google Scholar
Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV . (2003). An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol4: R69. ArticlePubMedPubMed Central Google Scholar